Cross-sectional nationwide epidemiologic survey on quality of life and treatment efficacy in Japanese patients with congenital ichthyoses

Yuika Suzuki; Kana Tanahashi; Chiaki Terashima-Murase; Takuya Takeichi; Yumiko Kobayashi; Fumie Kinoshita; Masashi Akiyama

doi:10.1016/j.jdermsci.2023.11.002

journal article Open Access Jan 01, 2024

Cross-sectional nationwide epidemiologic survey on quality of life and treatment efficacy in Japanese patients with congenital ichthyoses

Yuika Suzuki Kana Tanahashi Chiaki Terashima-Murase Takuya Takeichi Yumiko Kobayashi Fumie Kinoshita

Masashi Akiyama

Journal of Dermatological Science Vol. 113 No. 1 pp. 2-9 · Elsevier BV

View at Publisher Save 10.1016/j.jdermsci.2023.11.002

Topics

No keywords indexed for this article. Browse by subject →

References

23

[1]

Oji "Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009" J. Am. Acad. Dermatol. (2010) 10.1016/j.jaad.2009.11.020

[2]

Murase "Cross-sectional survey on disease severity in Japanese patients with harlequin ichthyosis/ichthyosis: syndromic forms and quality-of-life analysis in a subgroup" J. Dermatol. Sci. (2018) 10.1016/j.jdermsci.2018.08.008

[3]

Abeni "The burden of autosomal recessive congenital ichthyoses on patients and their families: an Italian multicentre study" Acta Derm. Venereol. (2021)

[4]

Sun "Ichthyosis affects mental health in adults and children: a cross-sectional study" J. Am. Acad. Dermatol. (2020) 10.1016/j.jaad.2020.01.052

[5]

Mazereeuw-Hautier "Management of congenital ichthyoses: European guidelines of care, part one" Br. J. Dermatol. (2019) 10.1111/bjd.17203

[6]

Joosten "New developments in the molecular treatment of ichthyosis: review of the literature" Orphanet J. Rare Dis. (2022) 10.1186/s13023-022-02430-6

[7]

World Medical Association, World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects, 〈https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/〉, 2022 (accessed 6 August 2023).

[8]

Bodemer "Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis" Br. J. Dermatol. (2011) 10.1111/j.1365-2133.2011.10510.x

[9]

Luchsinger "Secukinumab therapy for netherton syndrome" JAMA Dermatol. (2020) 10.1001/jamadermatol.2020.1019

[10]

Mazereeuw-Hautier "Management of congenital ichthyoses: European guidelines of care, part two" Br. J. Dermatol. (2019) 10.1111/bjd.16882

[11]

Cakmak "Chanarin-Dorfman syndrome: a comprehensive review" Liver Int (2021) 10.1111/liv.14794

[12]

Finlay "Dermatology Life Quality Index (DLQI)―a simple practical measure for routine clinical use" Clin. Exp. Dermatol. (1994) 10.1111/j.1365-2230.1994.tb01167.x

[13]

Lewis-Jones "The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use" Br. J. Dermatol. (1995) 10.1111/j.1365-2133.1995.tb16953.x

[14]

Lewis-Jones "The infants’ dermatitis quality of life index" Br. J. Dermatol. (2001) 10.1046/j.1365-2133.2001.03960.x

[15]

Cardiff University, Quality of life questionnaires. 〈https://www.cardiff.ac.uk/medicine/resources/quality-of-life-questionnaires〉, 2023 (accessed 8 August 2023).

[16]

Sakai "ABCA12 is a major causative gene for non-bullous congenital ichthyosiform erythroderma" J. Invest Dermatol. (2009) 10.1038/jid.2009.23

[17]

Basra "The dermatology life quality index 1994-2007: a comprehensive review of validation data and clinical results" Br. J. Dermatol. (2008)

[18]

Salek "Clinical experience and psychometric properties of the Children’s Dermatology Life Quality Index (CDLQI), 1995-2012" Br. J. Dermatol. (2013) 10.1111/bjd.12437

[19]

Basra "Infants’ dermatitis quality of life index: a decade of experience of validation and clinical application" Br. J. Dermatol. (2013) 10.1111/bjd.12563

[20]

Guidelines of care for the management of atopic dermatitis

Lawrence F. Eichenfield, Wynnis L. Tom, Sarah L. Chamlin et al.

Journal of the American Academy of Dermatology 2014 10.1016/j.jaad.2013.10.010

[21]

Mattei "Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies" J. Eur. Acad. Dermatol. Venereol. (2014) 10.1111/jdv.12106

[22]

Heymann "Retinoids in ichthyosis and disorders of cornification: tipping the scales toward optimal use" J. Am. Acad. Dermatol. (2022) 10.1016/j.jaad.2021.10.022

[23]

Barnes "Vehicles for drug delivery and cosmetic moisturizers: review and comparison" Pharmaceutics (2021) 10.3390/pharmaceutics13122012

Metrics

5

Citations

23

References

Details

Published: Jan 01, 2024
Vol/Issue: 113(1)
Pages: 2-9
License: View

Authors

Chiaki Terashima-Murase

Department of Advanced Medicine, Data Science Division, Data Coordinating Center, Nagoya University Hospital, Nagoya, Aichi, Japan

F

Fumie Kinoshita

Department of Advanced Medicine, Data Science Division, Data Coordinating Center, Nagoya University Hospital, Nagoya, Aichi, Japan

M

Masashi Akiyama

Funding

Japan Society for the Promotion of Science Award: 18H02832

Japan Science and Technology Agency Award: JPMJFR210R

Ministry of Health, Labour and Welfare Award: 20FC1052

Cite This Article

Yuika Suzuki, Kana Tanahashi, Chiaki Terashima-Murase, et al. (2024). Cross-sectional nationwide epidemiologic survey on quality of life and treatment efficacy in Japanese patients with congenital ichthyoses. Journal of Dermatological Science, 113(1), 2-9. https://doi.org/10.1016/j.jdermsci.2023.11.002

Cross-sectional nationwide epidemiologic survey on quality of life and treatment efficacy in Japanese patients with congenital ichthyoses

You May Also Like